Cargando…

Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets

Kinases are therapeutically actionable targets. Kinase inhibitors targeting vascular endothelial growth factor receptors (VEGFR) and mammalian target of rapamycin (mTOR) improve outcomes in metastatic clear cell renal cell carcinoma (ccRCC), but are not curative. Metastatic tumor tissue has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghatalia, Pooja, Yang, Eddy S., Lasseigne, Brittany N., Ramaker, Ryne C., Cooper, Sara J., Chen, Dongquan, Sudarshan, Sunil, Wei, Shi, Guru, Arjun S., Zhao, Amy, Cooper, Tiffiny, Della Manna, Deborah L., Naik, Gurudatta, Myers, Richard M., Sonpavde, Guru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004806/ https://www.ncbi.nlm.nih.gov/pubmed/27574806 http://dx.doi.org/10.1371/journal.pone.0160924

Ejemplares similares

Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma
por: Ghosh, Arindam P., et al.
Publicado: (2017)

Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets
por: Yang, Eddy S., et al.
Publicado: (2017)

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes
por: Anderson, Joshua C., et al.
Publicado: (2015)

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development
por: Zhao, Amy, et al.
Publicado: (2015)

RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature
por: Ramaker, Ryne C., et al.
Publicado: (2017)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
por: Gourdin, Theodore, et al.
Publicado: (2018)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

aRNApipe: a balanced, efficient and distributed pipeline for processing RNA-seq data in high-performance computing environments
por: Alonso, Arnald, et al.
Publicado: (2017)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
por: Thomas, Jonathan, et al.
Publicado: (2022)

New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib
por: Cowey, C Lance, et al.
Publicado: (2010)

Emerging Therapies in Penile Cancer
por: Alencar, Antonio Machado, et al.
Publicado: (2022)

Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
por: Nowsheen, Somaira, et al.
Publicado: (2012)

Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns
por: Kirby, Marie K., et al.
Publicado: (2017)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Lohiya, Vipin, et al.
Publicado: (2016)

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition
por: Ramaker, Ryne C., et al.
Publicado: (2021)

TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling
por: Gao, Song, et al.
Publicado: (2022)

A genome-wide interactome of DNA-associated proteins in the human liver
por: Ramaker, Ryne C., et al.
Publicado: (2017)

Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma
por: Zeng, Ling, et al.
Publicado: (2017)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study
por: Buonerba, Carlo, et al.
Publicado: (2016)

Precision Medicine to Treat Urothelial Carcinoma—The Way Forward
por: Luceno, Carvy Floyd, et al.
Publicado: (2023)

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
por: Ghatalia, P, et al.
Publicado: (2015)

Dissecting the regulatory activity and sequence content of loci with exceptional numbers of transcription factor associations
por: Ramaker, Ryne C., et al.
Publicado: (2020)

Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
por: Paluri, Ravi K., et al.
Publicado: (2019)

Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation
por: Savic, Daniel, et al.
Publicado: (2016)

DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma
por: Weaver, Alice N., et al.
Publicado: (2015)

Epigenetics in Prostate Cancer
por: Albany, Costantine, et al.
Publicado: (2011)

Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma
por: Nicolas, Emmanuelle, et al.
Publicado: (2019)

Role of perioperative immunotherapy in localized renal cell carcinoma
por: Kaur, Jasmeet, et al.
Publicado: (2023)

DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma
por: Lasseigne, Brittany N, et al.
Publicado: (2014)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

Post-mortem molecular profiling of three psychiatric disorders
por: Ramaker, Ryne C., et al.
Publicado: (2017)

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
por: Rehman, Hasibur, et al.
Publicado: (2022)

Synthesis and evaluation of MePEG-PCL diblock copolymers: surface properties and controlled release behavior
por: Mohanty, Anjan Kumar, et al.
Publicado: (2015)

MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines
por: Rohrbach, Timothy D., et al.
Publicado: (2017)

Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States
por: Galsky, Matthew D., et al.
Publicado: (2018)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
por: Zhang, Tian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_msfrp6ogs3dvofgk8c2fnebqih